Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Filspari
Pharma
Travere's bid to gain new approval for Filspari hits FDA hitch
After asking for additional information on the drug's clinical benefit a few weeks ago, the FDA has delayed its decision on Filspari to treat FSGS.
Kevin Dunleavy
Jan 14, 2026 11:22am
Chugai strikes $200M deal for IgAN asset in Asian countries
Oct 24, 2025 9:40am
Travere pauses trial enrollment over manufacturing scale-up woes
Sep 27, 2024 9:26am
Despite trial scare, Travere's IgAN drug wins full FDA approval
Sep 5, 2024 5:40pm
Novartis rides IgAN trioka to trial wins in rare kidney diseases
May 28, 2024 11:20am
EU regulator says yes to Tavere's Filspari, several other meds
Feb 23, 2024 12:12pm
